DESOUZA ERROL B - Insider Non-Derivative Transactions at Cyclerion Therapeutics, Inc. (CYCN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 30, 2023, DESOUZA ERROL B's relationship to Cyclerion Therapeutics, Inc. (CYCN) is Director, and currently has 50,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYCN insiders.
Data Source: SEC.
DESOUZA ERROL B - Insider Non-Derivative Transactions at CYCN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 1, 2023 | Acquisition -- (Common Stock) | 30000 | 0 | 30000 |
| Dec 1, 2023 | Acquisition -- (Common Stock) | 20000 | 0 | 50000 |